Day: August 31, 2021

Invalda INVL’s equity at the end of June this year was EUR 96.7 million, or EUR 8.23 per share. Equity per share was 15.75% larger than at the end of 2020. Invalda INVL earned a net profit of EUR 13 million in the first two quarters of the year, whereas in the same period last year it had a loss of EUR 4.2 million. The group’s  assets under management totalled EUR 1.44 billion at the end of the second quarter, which is 15% more than at the start of 2021 (when the amount was EUR 1.25 billion). Asset management business “The first half of the year was good for those investing and saving with the Invalda INVL group. Most of the group’s products did very well, generating a significant return for investors: overall, EUR 124.5 million were earned for clients in the period. Successful investment activities are driving growth in the assets entrusted...

As provided in Section XI ‘Calculation of the Net Asset Value’ of the Articles of Association of INVL Technology, the net asset value of the Company was EUR 35,037,213.09 or EUR 2.8777 per share on 30 June 2021. The person authorized to provide additional information: Kazimieras Tonkūnas INVL Technology Managing Partner E-mail k.tonkunas@invltechnology.lt

Montrouge, France, August 31, 2021 DBV Technologies to Participate at Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that DBV Technologies’ senior management team will participate in upcoming virtual investor conferences in September. Goldman Sachs Eleventh Annual Biotech Symposium Company management will participate in virtual investor meetings on September 7, 2021. Citi’s 16th Annual BioPharma Virtual ConferenceCompany management will participate in virtual investor meetings on September 8, 2021. H.C. Wainwright 23rd Annual Global Investment ConferenceThe pre-recorded fireside chat will be available on demand starting September 13, 2021 at 7:00 AM ET for the duration of the conference. A webcast of the fireside...

GHENT, Belgium, Aug. 31, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that it has appointed Jackie Fielding, a former Vice President of Medtronic with more than 30 years of experience in the healthcare industry, as an independent Non-Executive Director of the Company, effective as of 1 September 2021 upon approval by the Board of Directors. She replaces Jason Hannon who is stepping down from the Board of Directors due to his return to California. The appointment of Ms. Fielding will be submitted for confirmation to the Company’s next General Meeting of Shareholders. “We are delighted to welcome Jackie Fielding to our Board of Directors,” said Pierre Chauvineau,...

Amsterdam, August 31, 2021 – Arcadis (EURONEXT: ARCAD), the leading global Design & Consultancy organization for natural and built assets, today announced it is working with the Nederland Aardolie Maatschappij (NAM), a Dutch oil and gas company, to decommission 28 gas extraction sites. The goal is to return these locations safely and responsibly to their original state, which is mostly agricultural land. Arcadis with partners REYM, Van Vliet Sloopwerken, Bork, and Been Management Consulting will help NAM investigate if there are redevelopment opportunities at these locations such as energy hubs to support the energy transition in the region. Before dismantling each gas extraction site, an assessment will be conducted to determine if part of the site can be redeveloped. In collaboration with the various stakeholders (land owners, residents,...